Other NICE guidance referred to in this guideline
-
Overweight and obesity management (2025) NICE guideline NG246
-
Cardiovascular disease: risk assessment and reduction, including lipid modification (2023) NICE guideline NG238
-
Tobacco: preventing uptake, promoting quitting and treating dependence (2021) NICE guideline NG209
-
Type 2 diabetes prevention: population and community-level interventions (2011) NICE guideline PH35
-
Medicines adherence (2009) NICE guideline CG76
-
Cardiovascular disease prevention (2010) NICE guideline PH25
-
Alcohol-use disorders: prevention (2010) NICE guideline PH24
-
Depression in children and young people (2019) NICE guideline NG134
-
Ustekinumab for the treatment of adults with moderate to severe psoriasis (2009) NICE technology appraisal guidance 180
-
Adalimumab for psoriasis (2008) NICE technology appraisal guidance 146
-
Depression in adults with a chronic physical health problem (2009) NICE guideline CG91
-
Physical activity for children and young people (2009) NICE guideline PH17
-
Physical activity in the workplace (2008) NICE guideline PH13
-
Infliximab for psoriasis (2008) NICE technology appraisal guidance 134
-
Four commonly used methods to increase physical activity (2006) NICE guideline PH2
-
Etanercept and efalizumab for psoriasis (2006) NICE technology appraisal guidance 103
ISBN: 978-1-4731-6901-2